Clinical Trials on Mild to Moderate Psychopathological Symptoms

Total 3076 results

Mundipharma Research GmbH & Co KG

Completed

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

Subjects With Moderate to Severe, Chronic Nonmalignant Pain
Taisho Pharmaceutical Co., Ltd.

Completed

A Pharmacokinetic Study of TS-142 in Patients With Hepatic Impairment

Patients With Mild or Moderate Hepatic Impairment

Japan
University of California, San Francisco

Not yet recruiting

Treating Major Depression With Yoga Mono-therapy

Depression Moderate | Depression Mild

United States
University of Bern

Completed

Factorial Trial Investigating Outcome and Adherence Relevant Factors in an Online Self-help Intervention for Depression (HERMES)

Depression Moderate | Depression Mild

Switzerland
Gazi University

Completed

Cognitive Behavioral Therapy-Based Group Counseling (CBTBGC)

Depression Moderate | Depression Mild

Turkey
International Centre for Diarrhoeal Disease Research...

Completed

Feasible Means to Address Moderately Malnourished Children Within BINP Communities

Mild and Moderate Malnourished Children
Federal Research Center of Fundamental and Translational...

Completed

Real-time fMRI Neurofeedback for Mild/Moderate Depression

Depression Moderate | Depression Mild

Russian Federation
Charite University, Berlin, Germany

Completed

Modification of Pavlovian and Instrumental Learning in Human Addiction

Healthy | Alcohol Use Disorder (Mild vs. Moderate to Heavy)

Germany
Frontier Biotechnologies Inc.

Recruiting

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

Mild to Moderate COVID-19

China
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Study on Human Mass Balance of SPH3127 Tablets

Primary Mild and Moderate Hypertension

China
Bristol-Myers Squibb
Nitto Denko Corporation

Completed

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)

Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)

Bulgaria, United States
Ain Shams University

Completed

A Newly Modified Technique for Levator Muscle Tucking in Blepharoptosis Surgery: An Egyptian Tertiary Center Study (Lidtucking)

Mild Ptosis | Moderate Ptosis

Egypt
Astellas Pharma Europe B.V.

Completed

A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects

Healthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic Impairment

Slovakia
Alexandria University
Assoc. Prof. Ayman Ibrahim Baess; Dr. Noha Alaa Eldine Hassan Hamdy; Ph. Hanya...

Recruiting

Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease

Mild-to-moderate COVID-19

Egypt
Regenera Pharma Ltd

Completed

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

Mild to Moderate Dementia Due to Alzheimer's Disease | With or Without Coexisting Cerebrovascular Disease

Canada
MEDA PHARMA SPA, a Viatris company

Not yet recruiting

Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis. (Elidel-SEA)

Mild to Moderate Atopic Dermatitis
Creabilis SA

Terminated

CT 327 in the Treatment of Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Switzerland
Kintsugi Mindful Wellness, Inc.
Sonar Strategies; Vituity Psychiatry

Recruiting

Kintsugi Voice Device Pilot Study

Depression | Depression Moderate | Depression Severe | Depression Mild

United States
NovoBliss Research Pvt Ltd
Collagen Lifesciences Private Limited

Completed

A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments

Healthy | Osteoarthritis, Knee | Brittle Nails | Mild to Moderate Acne | Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1 | Other Specified Diseases of Hair and Hair Follicles

India
Eurofarma Laboratorios S.A.

Completed

A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

Mild to Moderate Persistent Allergic Rhinitis

Brazil
Ipsen

Recruiting

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines (LANTIC)

Moderate to Severe Upper Facial Lines

Germany, France
Wake Forest University Health Sciences

Active, not recruiting

Eucrisa for Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Sterna Biologicals GmbH & Co. KG

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema

Mild to Moderate Atopic Dermatitis

Germany
Bitop AG

Completed

Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
University of California, San Francisco

Recruiting

Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2

Depression Moderate | Depression Mild | Depression, Teen

United States
University Ghent
Universiteit Antwerpen; Janssen-Cilag Ltd.

Recruiting

Integrated Depression Care (IDECA)

Depression Moderate | Depression Severe | Depression Mild

Belgium
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Mild to Moderate Atopic Dermatitis
Greenpharma S.A.S.
Complife Italia S.r.l

Completed

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Italy
HanAll BioPharma Co., Ltd.

Completed

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Bayer

Completed

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
KoBioLabs
Novotech (Australia) Pty Limited

Completed

Study of Multiple Ascending Dose of KBL693 in Healthy Participants

Moderate to Severe Asthma

Australia
BioPharmX, Inc.

Completed

Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

Moderate to Severe Papulopustular Rosacea

United States
Novartis

Completed

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Moderate to Severe Hypertension

Russian Federation, Romania, Singapore, Spain, Germany, Philippines
Philipps University Marburg Medical Center

Completed

Long-term Effects ReSet Your Mind - Mechanisms

Depression Moderate | Depression Mild

Germany
Cytos Biotechnology AG

Completed

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Mild Essential Hypertension | Moderate Essential Hypertension

Switzerland
Centre Hospitalier Universitaire de Nice

Completed

Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid (TEO FIRST)

- Mild and Moderate Presbycusis (20 to 50 dB Average Hearing Loss at 500, 1000, 2000 Hz and 4000 Hz)

France
University of Victoria

Completed

Feasibility Study of an Online Physical Activity Intervention for Youth With Depression

Moderate Depression | Inactivity, Physical | Low Mood | Mild Depression

Canada
Mead Johnson Nutrition

Withdrawn

Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas

Cow's Milk Allergy | Intolerance to Extensively Hydrolyzed Formulas | Intolerance to Breast Milk

United Kingdom
Actavis Inc.

Completed

Clinical Endpoint Study of Ivermectin 1% Cream

Moderate to Severe Papulopustular Rosacea

United States
Mundipharma Research GmbH & Co KG

Completed

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

Moderate to Severe Idiopathic RLS With Daytime Symptoms

Spain, Sweden, Germany
University of Warsaw

Not yet recruiting

Online Mindfulness-Based Cognitive Therapy in Depressed Sample (iMBCT)

Moderate Depressive Episode | Mild Depressive Episode
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes (AWARENESS)

Prediabetes | Depressive Symptoms Mild to Moderate in Severity

United States
Wake Forest University Health Sciences

Completed

Biologics Anchoring Study

Moderate-to-severe Psoriasis

United States
Merck KGaA, Darmstadt, Germany

Completed

CLEAR Study: Clinical Experience Acquired With Raptiva Study

Moderate to Severe Psoriasis

Switzerland
Merck KGaA, Darmstadt, Germany

Completed

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Moderate to Severe Psoriasis

Switzerland
Pfizer

Completed

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Moderate to Severe Psoriasis

Korea, Republic of
Edwards Lifesciences

Terminated

Hypotension Prediction Index (HPI) SMART-BP Trial

Moderate to High-risk Noncardiac Surgery

United States
Shanghai Junshi Bioscience Co., Ltd.

Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

Moderate to Severe Psoriasis

China
Bristol-Myers Squibb

Terminated

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Psoriasis, Moderate to Severe

United States
GC Cell Corporation

Recruiting

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Moderate to Severe Plaque Psoriasis

Korea, Republic of

Clinical Trials on Mild to Moderate Psychopathological Symptoms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations